{"id":"NCT01811485","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy","officialTitle":"A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 14 Weeks Treatment With LMF237 Bid to Placebo in Patients With Type 2 Diabetes Inadequately Controlled With Vildagliptin 50 mg Bid Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05","primaryCompletion":"2014-02","completion":"2014-02","firstPosted":"2013-03-14","resultsPosted":"2015-02-23","lastUpdate":"2015-02-23"},"enrollment":171,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"LMF237 50/250 mg","otherNames":[]},{"type":"DRUG","name":"LMF237 50/500 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"LMF237 50/250 mg","type":"EXPERIMENTAL"},{"label":"LMF237 50/500 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study was to evaluate the efficacy and safety of LMF237 50/250 mg and 50/500 mg bid in Japanese patients with T2DM inadequately controlled with vildagliptin monotherapy. This study was conducted to support registration of the fixed-dose combination of vildagliptin and metformin for the treatment of T2DM in Japan.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 14 Weeks Between Treatment Groups","timeFrame":"Baseline to 14 weeks","effectByArm":[{"arm":"Pooled LMF237","deltaMin":-0.83,"sd":0.06},{"arm":"Placebo","deltaMin":0.14,"sd":0.08}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":30,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":115},"commonTop":["Nasopharyngitis","Nausea","Gastritis","Asthenia","Constipation"]}}